Skip to main content

Corporate insider profile

Kevin McCulloch Insider Trades

Latest reported as See Remarks of Xeris Biopharma Holdings, Inc. (XERS).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,361,179.00
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale15,000$9.41$141,120
Sep 28, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale25,000$10.00$250,000
Sep 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale15,000$8.49$127,308
Aug 3, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale15,000$8.02$120,240
Jul 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale90,000$8.03$722,511